Mitotherapeutix LLC
1 known investors
Mitotherapeutix develops siRNA-based drugs targeting mitochondrial metabolic regulation through RNA silencing. The company focuses on treating a broad range of diseases by modulating a metabolic regulator in the mitochondria.
AI & Machine LearningBiotechMedical Devices